GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Return-on-Tangible-Asset

Microba Life Sciences (ASX:MAP) Return-on-Tangible-Asset : -51.28% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Microba Life Sciences's annualized Net Income for the quarter that ended in Dec. 2023 was A$-22.98 Mil. Microba Life Sciences's average total tangible assets for the quarter that ended in Dec. 2023 was A$44.81 Mil. Therefore, Microba Life Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was -51.28%.

The historical rank and industry rank for Microba Life Sciences's Return-on-Tangible-Asset or its related term are showing as below:

ASX:MAP' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -39.81   Med: -30.18   Max: -29.7
Current: -39.81

During the past 2 years, Microba Life Sciences's highest Return-on-Tangible-Asset was -29.70%. The lowest was -39.81%. And the median was -30.18%.

ASX:MAP's Return-on-Tangible-Asset is ranked worse than
70.13% of 231 companies
in the Medical Diagnostics & Research industry
Industry Median: -9.45 vs ASX:MAP: -39.81

Microba Life Sciences Return-on-Tangible-Asset Historical Data

The historical data trend for Microba Life Sciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Return-on-Tangible-Asset Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Return-on-Tangible-Asset
-29.70 -30.65

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset - - -25.71 -29.85 -51.28

Competitive Comparison of Microba Life Sciences's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Microba Life Sciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microba Life Sciences's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Return-on-Tangible-Asset falls into.



Microba Life Sciences Return-on-Tangible-Asset Calculation

Microba Life Sciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-12.68/( (38.625+44.106)/ 2 )
=-12.68/41.3655
=-30.65 %

Microba Life Sciences's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-22.976/( (44.106+45.51)/ 2 )
=-22.976/44.808
=-51.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


Microba Life Sciences  (ASX:MAP) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Microba Life Sciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines